Pharmacy Students' Ability to Identify Potential Drug-Drug Interactions

被引:11
|
作者
Saverno, Kim R. [1 ]
Malone, Daniel C. [1 ]
Kurowsky, John [1 ]
机构
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
关键词
drug interaction; ALERTS; RECOGNITION; KNOWLEDGE; RISK;
D O I
10.5688/aj730227
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objective. To evaluate the ability of third- and fourth-year pharmacy students to identify clinically significant drug-drug interactions (DDIs) Methods. A questionnaire designed to measure DDI knowledge was disseminated to fourth-year pharmacy students in a school of pharmacy. A second questionnaire was distributed to third- year pharmacy students in 2 schools of pharmacy (schools A and B) and re-administered to students in 1 of the schools 1 year later. Results. Class of 2005 fourth-year pharmacy students correctly categorized an average of 52% +/- 13% DDI pairs on the first questionnaire. Third-year pharmacy students at schools A and B correctly categorized an average of 61% +/- 18% and 66% +/- 15% of DDI pairs, respectively. The average percentage of correct responses for fourth-year students from the class of 2007 was 65% (+/- 17%). Conclusion. Pharmacy students' ability to identify important DDIs is far from optimal, even after completing experiential requirements.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Assessment of Potential Drug-Drug Interactions of Psycholeptics and Antidepressants in Outpatient Settings
    Marovic, Iva
    Marinovic, Ivana
    Vrca, Vesna Bacic
    Samardzic, Ivana
    PHARMACY, 2024, 12 (06)
  • [22] Generating Evidence of Clinical Outcomes of Drug-Drug Interactions
    Bykov, Katsiaryna
    Gagne, Joshua J.
    DRUG SAFETY, 2017, 40 (02) : 101 - 103
  • [23] A drug-drug interaction knowledge assessment instrument for health professional students: A Rasch analysis of validity evidence
    Warholak, Terri L.
    Menke, J. Michael
    Hines, Lisa E.
    Murphy, John E.
    Reel, Sally
    Malone, Daniel C.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2011, 7 (01) : 16 - 26
  • [24] Knowledge and information sources of potential drug-drug interactions of healthcare professionals among Buraydah Hospitals
    Abougalambou, Salwa Selim Ibrahim
    Alenezi, Tief Naif
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [25] Drug-Drug Interactions with Anticoagulants and Antiplatelets
    Ross, Patricia A.
    Wellman, Jessica C.
    Streiff, Michael B.
    HOSPITAL MEDICINE CLINICS, 2013, 2 (01) : E130 - +
  • [26] Important Drug-Drug Interactions in the Elderly
    Ruth M. Seymour
    Philip A. Routledge
    Drugs & Aging, 1998, 12 : 485 - 494
  • [27] Drug-Drug Interactions in Headache Medicine
    Ansari, Hossein
    Ziad, Sanaz
    HEADACHE, 2016, 56 (07): : 1241 - 1248
  • [28] Aprepitant: drug-drug interactions in perspective
    Aapro, M. S.
    Walko, C. M.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2316 - 2323
  • [29] Potential drug-drug and drug-disease interactions in well-functioning community-dwelling older adults
    Hanlon, J. T.
    Perera, S.
    Newman, A. B.
    Thorpe, J. M.
    Donohue, J. M.
    Simonsick, E. M.
    Shorr, R. I.
    Bauer, D. C.
    Marcum, Z. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (02) : 228 - 233
  • [30] Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir
    Brandariz-Nunez, David
    Correas-Sanahuja, Marcelo
    Guarc, Eva
    Picon, Rafael
    Garcia, Barbara
    Gil, Rocio
    MEDICINA CLINICA, 2020, 155 (07): : 281 - 287